期刊文献+

Clinical applications of high-throughput genetic diagnosis in inherited retinal dystrophies: Present challenges and future directions

Clinical applications of high-throughput genetic diagnosis in inherited retinal dystrophies: Present challenges and future directions
下载PDF
导出
摘要 The advent of next generation sequencing(NGS) tech-niques has greatly simplified the molecular diagnosis and gene identification in very rare and highly heterogeneous Mendelian disorders. Over the last two years, these approaches, especially whole exome sequencing(WES), alone or combined with homozygosity mapping and linkage analysis, have proved to be successful in the identification of more than 25 new causative retinal dystrophy genes. NGS-approaches have also identified a wealth of new mutations in previously reported genes and have provided more comprehensive information concerning the landscape of genotype-phenotype correlations and the genetic complexity/diversity of human control populations. Although whole genome sequencing is far more informative than WES, the functional meaning of the genetic variants identified by the latter can be more easily interpreted, and final diagnosis of inherited retinal dystrophies is extremely successful, reaching 80%, particularly for recessive cases. Even considering the present limitations of WES, the reductions in costs and time, the continual technical improvements, the implementation of refined bioinformatic tools and the unbiased comprehensive genetic information it provides, make WES a very promising diagnostic tool for routine clinical and genetic diagnosis in the future. The advent of next generation sequencing (NGS) tech-niques has greatly simplified the molecular diagnosis and gene identification in very rare and highly heterogeneous Mendelian disorders. Over the last two years, these approaches, especially whole exome sequencing (WES), alone or combined with homozygosity mapping and linkage analysis, have proved to be successful in the identification of more than 25 new causative retinal dystrophy genes. NGS-approaches have also identified a wealth of new mutations in previously reported genes and have provided more comprehensive information concerning the landscape of genotype-phenotype corre-lations and the genetic complexity/diversity of human control populations. Although whole genome sequencing is far more informative than WES, the functional meaning of the genetic variants identified by the latter can be more easily interpreted, and final diagnosis of inherited retinal dystrophies is extremely successful, reaching 80%, particularly for recessive cases. Even considering the present limitations of WES, the reductions in costs and time, the continual technical improvements, the implementation of refined bioinformatic tools and the unbiased comprehensive genetic information it provides, make WES a very promising diagnostic tool for routine clinical and genetic diagnosis in the future.
出处 《World Journal of Medical Genetics》 2015年第2期14-22,共9页 世界医学遗传学杂志
基金 Supported by Grants SAF2013-49069-C2-1-R(Marfany G and Gonzàlez-Duarte R) BFU2010-15656(Marfany G)(Ministerio de Ciencia e Innovación) SGR2014-0932(Generalitat de Catalunya) CIBERER(U718) Retina Asturias(Gonzàlez-Duarte R) ONCE(Gonzàlez-Duarte R)
关键词 Next generation SEQUENCING Identification of novel CAUSATIVE genes INHERITED RETINAL dystrophies Genetic diagnosis Whole EXOME SEQUENCING Next generation sequencing Identification of novel causative genes Inherited retinal dystrophies Genetic diagnosis Whole exome sequencing
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部